Literature DB >> 8426030

Public opinion regarding consent to treatment.

P A Singer1, S Choudhry, J Armstrong.   

Abstract

OBJECTIVE: To examine public opinion regarding certain elements of consent: disclosure, advance directives, substitute decisions, emergency treatment, and advocacy.
DESIGN: Cross-sectional random-digit-dialing telephonic survey.
SETTING: General public. PARTICIPANTS: One thousand randomly-selected adults living in Ontario.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Self-reported attitudes and behaviors.
RESULTS: Of 5,708 telephone numbers drawn, 641 were non-valid or non-residential, 1,283 were not in service, 1,068 had no answer, a busy line, or an unavailable respondent, 147 subjects had a language barrier, 1,497 subjects refused, 72 interviews were incomplete, and 1,000 interviews were completed. With regard to disclosure, 33% of respondents said that a doctor should withhold information from a patient if asked to do so by the patient's family. With regard to advance directives, 36% of respondents had had advance discussions with their families, and 12% had completed a living will. With regard to substitute decisions, 77% of respondents said that they would went their wishes followed if they were unable to make medical decisions for themselves; 58% wanted their spouse or partner to make such decisions for them. With regard to emergency treatment, 48% of respondents stated that a doctor should give a life-saving blood transfusion to an unconscious adult carrying a card stating that blood transfusion was against his or her religious beliefs. With regard to advocacy, 78% of respondents supported mandatory advocacy services for serious health decisions such as whether to have heart surgery; 33% supported advocacy services for less serious decisions such as whether to have a dental filling.
CONCLUSIONS: These data highlight the need to reconsider legislative provisions regarding and/or target public education programs toward specific consent-related issues including disclosure, advance directives, substitute decisions, emergency treatment, and advocacy.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Professional Patient Relationship

Mesh:

Year:  1993        PMID: 8426030     DOI: 10.1111/j.1532-5415.1993.tb02042.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  7 in total

Review 1.  Advance directives in family practice.

Authors:  N Kohut; P A Singer
Journal:  Can Fam Physician       Date:  1993-05       Impact factor: 3.275

2.  The HIV-specific advance directive.

Authors:  P A Singer; E C Thiel; I Salit; W Flanagan; C D Naylor
Journal:  J Gen Intern Med       Date:  1997-12       Impact factor: 5.128

3.  Bioethics for clinicians: 6. Advance care planning.

Authors:  P A Singer; G Robertson; D J Roy
Journal:  CMAJ       Date:  1996-12-15       Impact factor: 8.262

4.  Hospital policies on life-sustaining treatments and advance directives in Canada.

Authors:  I Rasooly; J V Lavery; S Urowitz; S Choudhry; N Seeman; E M Meslin; F H Lowy; P A Singer
Journal:  CMAJ       Date:  1994-04-15       Impact factor: 8.262

Review 5.  Challenges in end-of-life care in the ICU. Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003.

Authors:  Jean Carlet; Lambertus G Thijs; Massimo Antonelli; Joan Cassell; Peter Cox; Nicholas Hill; Charles Hinds; Jorge Manuel Pimentel; Konrad Reinhart; Boyd Taylor Thompson
Journal:  Intensive Care Med       Date:  2004-04-20       Impact factor: 17.440

6.  Respiratory support withdrawal in intensive care units: families, physicians and nurses views on two hypothetical clinical scenarios.

Authors:  Renata R L Fumis; Daniel Deheinzelin
Journal:  Crit Care       Date:  2010-12-29       Impact factor: 9.097

7.  Physician-facilitated designation of proxy decision-makers: family physician perceptions.

Authors:  Gideon Lifshitz; Matan J Cohen; Hila Shmilovitz; Mayer Brezis; Amnon Lahad; Arie Ben-Yehuda
Journal:  Isr J Health Policy Res       Date:  2016-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.